Academy Supports Legislation to Address Infant Formula Shortage

05/18/2022 - This week, two bills intended to ensure that infant formula scarcity is avoided in the future and that the U.S. Food and Drug Administration has resources to support safety and oversight were introduced.

The bipartisan Access to Baby Formula Act will provide regulatory relief and maximum flexibility to Women, Infants and Children Supplemental Nutrition Program providers as they support low-income families during product recalls and public health emergencies.

The Infant Formula Supplemental Appropriations Act of 2022 would provide $28 million in funding for FDA to address product shortages and strengthens the agency's capacity to assure safety of infant formula, especially as new products enter the domestic market.

The Academy added its name to a letter being sent to congressional leaders in support of the bills urging for swift action to resolve the current infant formula shortage to ensure babies continue to have access to nutrition.